Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Titel:
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Auteur:
Middleton, Gary Silcocks, Paul Cox, Trevor Valle, Juan Wadsley, Jonathan Propper, David Coxon, Fareeda Ross, Paul Madhusudan, Srinivasan Roques, Tom Cunningham, David Falk, Stephen Wadd, Nick Harrison, Mark Corrie, Pippa Iveson, Tim Robinson, Angus McAdam, Karen Eatock, Martin Evans, Jeff Archer, Caroline Hickish, Tamas Garcia-Alonso, Angel Nicolson, Marianne Steward, William Anthoney, Alan Greenhalf, William Shaw, Victoria Costello, Eithne Naisbitt, Dean Rawcliffe, Charlotte Nanson, Gemma Neoptolemos, John